Human longevity company secures $39.8M to advance AI-driven breakthroughs
Longevity Technology - 22-Aug-2024Extending healthspan and lifespan through personalized, preventive care
Join the club for FREE to access the whole archive and other member benefits.
Founder, Chairman and CEO at J. Craig Venter Institute and Author
J. Craig Venter, PhD, is regarded as one of the leading scientists of the 21st century for his numerous invaluable contributions to genomic research. Dr. Venter is Founder, Chairman, and CEO of the J. Craig Venter Institute (JCVI), a not-for-profit, research organization with approximately 200 scientists and staff dedicated to human, microbial, plant, synthetic and environmental genomic research, and the exploration of social and ethical issues in genomics.
Dr. Venter also is a co-founder of Synthetic Genomics, Inc. (SGI) and Human Longevity, Inc. (HLI). SGI is a privately held company developing products and solutions including sustainable bio-fuels, vaccines, biotherapeutics and transplantable organs. HLI is a genomic-based, health intelligence company empowering proactive healthcare.
Visit website: https://www.jcvi.org/about/jcventer
See alsoDetails last updated 23-Jan-2020
Extending healthspan and lifespan through personalized, preventive care
Made possible by early detection of disease and disease risks through whole genome sequencing
Studies were done by integrating whole-genome sequencing with advanced imaging and blood metabolites
The new approach to healthcare: proactive preventative personalised predictive Life threaten...
They will not be old in mind or body, only in years. Likely to amplify economic inequality. Tho...
Genome editing combined with stem cell generation could produce life extending therapies when boosted with big data
Book about synthetic genomics written by J. Craig Venter